BlackRock Institutional Trust’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $31M | Buy |
1,228,844
+79,600
| +7% | +$2.01M | ﹤0.01% | 1643 |
|
|
2016
Q3 | $28.4M | Buy |
1,149,244
+165,346
| +17% | +$4.09M | ﹤0.01% | 1638 |
|
|
2016
Q2 | $20M | Buy |
983,898
+98,057
| +11% | +$2M | ﹤0.01% | 1845 |
|
|
2016
Q1 | $13.5M | Buy |
885,841
+12,073
| +1% | +$184K | ﹤0.01% | 2067 |
|
|
2015
Q4 | $11.7M | Buy |
873,768
+32,103
| +4% | +$431K | ﹤0.01% | 2219 |
|
|
2015
Q3 | $11.8M | Buy |
841,665
+235,695
| +39% | +$3.31M | ﹤0.01% | 2175 |
|
|
2015
Q2 | $10.3M | Buy |
605,970
+230,538
| +61% | +$3.91M | ﹤0.01% | 2388 |
|
|
2015
Q1 | $4.54M | Buy |
375,432
+98,299
| +35% | +$1.19M | ﹤0.01% | 2789 |
|
|
2014
Q4 | $2.3M | Sell |
277,133
-3,194
| -1% | -$26.5K | ﹤0.01% | 3038 |
|
|
2014
Q3 | $2.44M | Sell |
280,327
-25,413
| -8% | -$221K | ﹤0.01% | 2982 |
|
|
2014
Q2 | $3.35M | Buy |
305,740
+111,669
| +58% | +$1.22M | ﹤0.01% | 2948 |
|
|
2014
Q1 | $1.74M | Buy |
194,071
+46,045
| +31% | +$412K | ﹤0.01% | 3212 |
|
|
2013
Q4 | $1.12M | Sell |
148,026
-7,416
| -5% | -$55.9K | ﹤0.01% | 3363 |
|
|
2013
Q3 | $1.14M | Buy |
155,442
+6,817
| +5% | +$50K | ﹤0.01% | 3324 |
|
|
2013
Q2 | $956K | Buy |
+148,625
| New | +$956K | ﹤0.01% | 3339 |
|